C Arnoulet
Overview
Explore the profile of C Arnoulet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Collette Y, Prebet T, Goubard A, Adelaide J, Castellano R, Carbuccia N, et al.
Blood Cancer J
. 2015 Mar;
5:e292.
PMID: 25768406
No abstract available.
2.
Mokart D, Textoris J, Chow-Chine L, Brun J, Sannini A, Turrini O, et al.
Minerva Anestesiol
. 2011 May;
77(5):522-7.
PMID: 21540807
Aim: HLA-DR monocyte expression may be affected by major surgery. A potential mechanism for monocyte activation is the engagement of costimulatory receptors (B7-2 or CD-86). The aim of the present...
3.
Lacombe F, Arnoulet C, Maynadie M, Lippert E, Luquet I, Pigneux A, et al.
Leukemia
. 2008 Nov;
23(2):350-7.
PMID: 18987664
An early appreciation of treatment efficacy could be very useful in acute myeloblastic leukemia (AML), and a prognostic value has been suggested for the morphological assessment of decrease in blasts...
4.
Aurran-Schleinitz T, Arnoulet C, Ivanov V, Coso D, Rey J, Schiano J, et al.
Rev Med Interne
. 2008 Mar;
29(5):424-35.
PMID: 18359538
Introduction: Chronic lymphocytic leukemia (CLL) is the most common leukaemia in the Western world. Recent advancement in the aetiology, pathophysiology and the development of new therapeutics tools have significantly modified...
5.
Ivanov V, Faucher C, Mohty M, Bilger K, Ladaique P, Sainty D, et al.
Bone Marrow Transplant
. 2005 Sep;
36(10):901-6.
PMID: 16151421
The use of recombinant human erythropoietin (rHuEPO) has been controversial after myeloablative allogeneic Stem cell transplantation (allo-SCT). Reduced intensity conditioning regimens (RIC) offer a novel approach that might translate into...
6.
Ivanov V, Faucher C, Mohty M, Bilger K, Ladaique P, Sainty D, et al.
Transfusion
. 2004 Mar;
44(4):501-8.
PMID: 15043564
Background: RBCT (RBCT) requirements of stem cell transplant (SCT) recipients are often substantial and may be related to transplant type. Study Design And Methods: An analysis was done of RBCT...
7.
Viret F, Chabannon C, Sainty D, Genre D, Goncalves A, Arnoulet C, et al.
Bone Marrow Transplant
. 2003 Nov;
32(11):1059-64.
PMID: 14625576
The purpose of this study was to evaluate the presence of micrometastatic cells in the apheresis products from patients with breast cancer, and also to determine if repeated infusion of...
8.
Mohty M, Faucher C, Vey N, Chabannon C, Sainty D, Arnoulet C, et al.
Leukemia
. 2002 Oct;
16(10):2129-33.
PMID: 12357367
Large granular lymphocyte (LGL) proliferation typically follows a chronic course during which major features are cytopenia and immune abnormalities. Elevated numbers of LGL were reported in a few cases following...
9.
Mohty M, Gaugler B, Faucher C, Sainty D, Lafage-Pochitaloff M, Vey N, et al.
Hematology
. 2002 Sep;
7(3):157-64.
PMID: 12243978
Approaches using reduced conditioning regimens have been developed to obtain minimal procedure-related toxicity. Such novel therapeutic options are being explored with good preliminary results concerning feasibility and engraftment. However, many...
10.
Costello R, Sivori S, Mallet F, Sainty D, Arnoulet C, Reviron D, et al.
Leukemia
. 2002 May;
16(5):855-60.
PMID: 11986947
We describe a patient with acute myeloid leukemia (AML) who developed polyclonal large granular lymphocyte (LGL) proliferation. The reciprocal evolution of AML and LGLs suggested that these LGLs had an...